Shujuan Li

1.6k citations
36 papers · 848 indexed · 1 hit paper · h-index 14
Topics
Retinal Development and Disorders (4 papers)Nanoparticle-Based Drug Delivery (3 papers)RNA modifications and cancer (3 papers)

In The Last Decade

Shujuan Li

33 papers receiving 843 citations

Hit Papers

Extracellular vesicle-based interorgan transport of mitoc...2021202620222024202150100150200250

Peers

Shujuan Li
Comparison fields: 5 of 104
  • Molecular Biology 423
  • Epidemiology 114
  • Pulmonary and Respiratory Medicine 113
  • Cancer Research 103
  • Biomedical Engineering 94
Replace Saeed Nazari Soltan Ahmad with:
Saeed Nazari Soltan Ahmad Iran
Xiaotian Li China
Chak Kwong Cheng Hong Kong
Danni Liu China
Bo Qiu China
Samaa Samir Kamar Egypt
Houxiang Hu China
Guangneng Liao China
Shujuan Li relative to Saeed Nazari Soltan Ahmad Iran Saeed Nazari Soltan Ahmad's profile →
Citations per field
00.5×3.1×
Saeed Nazari Soltan Ahmad · 1×
Citations per year

Countries citing papers authored by Shujuan Li

Since Specialization
Citations

This map shows the geographic impact of Shujuan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shujuan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shujuan Li more than expected).

Fields of papers citing papers by Shujuan Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shujuan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shujuan Li. The network helps show where Shujuan Li may publish in the future.

Co-authorship network of co-authors of Shujuan Li

This figure shows the co-authorship network connecting the top 25 collaborators of Shujuan Li. A scholar is included among the top collaborators of Shujuan Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shujuan Li. Shujuan Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 1
4 0
5 2
6 9
7 6
8 7
9 13
10 14
11 3
12 11
13 17
14 49
15 16
16 63
17 44
18 77
19 1
20 22

About Shujuan Li

Shujuan Li is a scholar working on Nephrology, Sensory Systems and Ophthalmology, having authored 36 papers that have together received 848 indexed citations. Recurring topics across this work include Retinal Development and Disorders (4 papers), Nanoparticle-Based Drug Delivery (3 papers) and RNA modifications and cancer (3 papers). The work is most often cited by research in Nephrology (58 citations), Cancer Research (103 citations) and Pharmaceutical Science (39 citations). Shujuan Li has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Yongzhong Du, Xiaoling Xu, Xu-Qi Kang, Xiaoying Ying, Hesham A. Sadek, Jingbo Hu, Christine M. Kusminski, Clair Crewe, Nolwenn Joffin and Christy Gliniak. Their work appears in journals such as Journal of Biological Chemistry, Circulation and Cell Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026